Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin

Enzastaurin is a pill taken daily vs placebo as maintenance therapy for Diffuse Large B-Cell Lymphoma patients at risk of relapse who have achieved complete remission with R-CHOP chemotherapy.